Foussias G, Taylor S M, Yousef G M, Tropak M B, Ordon M H, Diamandis E P
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
Biochem Biophys Res Commun. 2001 Jun 22;284(4):887-99. doi: 10.1006/bbrc.2001.5052.
The sialic acid binding immunoglobulin-like lectin (Siglec) family is a recently described member of the immunoglobulin superfamily. Within this Siglec family there exists a subgroup of molecules which bear a very high degree of homology with the molecule Siglec-3 (CD33), and has thus been designated the Siglec-3-like subgroup of Siglecs. The members of this subgroup have been localized to chromosome 19q13.4, through both in situ hybridization and precise genomic mapping at the nucleotide level. Through the positional cloning approach we have identified and characterized a Siglec-like gene (SLG), a putative novel member of the Siglec-3-like subgroup of Siglecs. We have characterized the complete genomic structure of SLG, as well as two alternative splice variants, and determined its chromosomal localization. The short isoform, SLG-S, consists of seven exons, with six intervening introns, while the longer isoform, SLG-L, consists of eight exons and seven intervening introns. The SLG gene is localized 32.9 kb downstream of Siglec-8 on chromosome 19q13.4. The putative SLG-S and SLG-L proteins, of 477 and 595 amino acid residues, respectively, show extensive homology to many members of the Siglec-3-like subgroup. This high degree of homology is conserved in the extracellular Ig-like domains, as well as in the cytoplasmic tyrosine-based motifs. Interestingly, the SLG-L protein contains two N-terminal V-set Ig-like domains, as opposed to SLG-S and other Siglec-3-like subgroup members which contain only one such domain. Through RT-PCR we have examined the expression profile of both SLG splice variants in a panel of human tissues and have found that SLG-S is highly expressed in spleen, small intestine and adrenal gland, while SLG-L exhibits high levels of expression in spleen, small intestine, and bone marrow. This gene is quite likely the latest novel member of the CD33-like subgroup of Siglecs, and given its high degree of homology, it may also serve a regulatory role in the proliferation and survival of a particular hematopoietic stem cell lineage, as has been found for CD33 and Siglec7.
唾液酸结合免疫球蛋白样凝集素(Siglec)家族是免疫球蛋白超家族中最近被描述的成员。在这个Siglec家族中,存在一个分子亚群,它们与Siglec-3(CD33)分子具有高度同源性,因此被指定为Siglec的Siglec-3样亚群。通过原位杂交和核苷酸水平的精确基因组定位,该亚群的成员已被定位到19号染色体q13.4区域。通过定位克隆方法,我们鉴定并表征了一个Siglec样基因(SLG),它是Siglec的Siglec-3样亚群中一个假定的新成员。我们已经表征了SLG的完整基因组结构以及两种可变剪接变体,并确定了其染色体定位。短异构体SLG-S由七个外显子和六个间隔内含子组成,而较长的异构体SLG-L由八个外显子和七个间隔内含子组成。SLG基因位于19号染色体q13.4上Siglec-8下游32.9 kb处。假定的SLG-S和SLG-L蛋白分别由477和595个氨基酸残基组成,与Siglec-3样亚群的许多成员具有广泛的同源性。这种高度同源性在细胞外Ig样结构域以及基于酪氨酸的细胞质基序中都得以保留。有趣的是,与仅包含一个此类结构域的SLG-S和其他Siglec-3样亚群成员不同,SLG-L蛋白包含两个N端V-set Ig样结构域。通过逆转录聚合酶链反应(RT-PCR),我们检测了SLG剪接变体在一组人类组织中的表达谱,发现SLG-S在脾脏、小肠和肾上腺中高表达,而SLG-L在脾脏、小肠和骨髓中表达水平较高。该基因很可能是Siglec的CD33样亚群的最新新成员,鉴于其高度同源性,它也可能在特定造血干细胞谱系的增殖和存活中发挥调节作用,正如在CD33和Siglec7中所发现的那样。